Perspective Article

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

Department of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen; TdW and LM both contributed equally as co-first authors
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia; TdW and LM both contributed equally as co-first authors
Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris
St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds
Department of Medicine, Division of Hematology, University of Patras Medical School, Patras
Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv
Department of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, Innsbruck
Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, and CIBERONC, Madrid
Department of Clinical Hematology, Inst. of Hematology and Blood Transfusion, Praha
Department of Hematology, Radboud University Medical Center, Nijmegen
Department of Medicine, Division Hematology, Karolinska Institutet, Stockholm
Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf
Department of Haematology, Aarhus University Hospital, Aarhus
Department of Haematology, Oncology and Internal Medicine, Warszawa Medical University, Warszawa
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest
Department of Clinical Hematology, Hospital da Luz, Lisbon
Clinic of Hematology - Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad
Department of Internal Medicine, Division of Hematology, Merkur University Hospital, Zagreb
Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris
Department of Hematology, Radboud University Medical Center, Nijmegen
Department of Specialist Medicine, Sahlgrenska University Hospital, Göteborg
Department of Haematology, Aberdeen Royal Infirmary, Aberdeen
Department of Hematology, Democritus University of Thrace Medical School, University Hospital of Alexandroupolis, Alexandroupolis
Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris
Department of Hematology – Cancer Center Amsterdam, Amsterdam UMC, Location VU University Medical Center, Amsterdam
Department of Hematology, Radboud University Medical Center, Nijmegen
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York
Haematologica Early view Sep 21, 2020 https://doi.org/10.3324/haematol.2020.266817